glp 1 agonist oral or injection GLP-1s GLP-1 Tablets vs Injection: Effectiveness

Evidence-based comparison of retatrutide (GIP/GLP-1/glucagon triple agonist) and survodutide (GLP-1/glucagon dual agonist) for weight loss, MASH, and metabolic disease based on Phase 2 clinical trial data.

Discover how GLP-1 receptor agonists are transforming womens weight loss care

Oral GLP-1 RA are also under development and early data shows similar WL efficacy to semaglutide 2.4mg

Some even suggest that GLP-1 agonists might have the potential to supplant MASH therapy in its entirety

Learn what patients and prescribers should know about lean mass, protein, and exercise.

Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a groundbreaking treatment for Type 2 diabetes mellitus (T2DM) and obesity